USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Trends that will Impact the Market in the Short Term
19-Dec-2014
Asia Pacific
Market Research
P860-01-00-00-00
LS00147-AP-MR_16988
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a significant percentage of products to the US and Europe. India, China, South Korea, and Japan are the important Asian markets. The generics industry has moved on after patent cliff, and is more focused on increasing product quality and market share. Overall, the global generics market will see an average growth in the next 2-3 years.
Executive Summary
Executive Summary (continued)
Executive Summary (continued)
Executive Summary (continued)
Executive Summary (continued)
Key Questions This Study Will Answer
Research Process and Methodology
What Will The Global Generics Market Look Like in 2015?
What Can We Expect in the Next Three Years?
Opportunities by Therapeutic Segments—Cardiovascular Disease Remains the Most Attractive Segment till 2018
Opportunities by Product Segments—Biologics or Oral Solids?
With Less Molecules To Lose Exclusivity, Will the Generics Industry Continue To Grow?
Major Losses Due To Patent Cliff in 2014
Selected Patent Expiries in 2015
Who Gets the Maximum Advantage Post Loss of Exclusivity (LOE) of Major Drugs?
Challenges for Drug Manufacturers
Major Models and Trends Post 2012 LOE
Activities in the Asian Generics Market
Major Approvals and New Products in Asia-Pacific Generics Market in 2014
Indian Generics Market
Indian Generics Market (continued)
Indian Market is Mix of Branded Generics and Un-branded Generics
Universal Health Coverage Scheme 2015–2019
Universal Health Coverage in India and its Implications
To Meet The Demands of Domestic Markets, Generic Manufacturers Have to Produce a Surplus
Markets Other than India to be Equally Lucrative for Generic Manufacturers
China
Chinese Generics Market in 2014
Generics Market Boom Likely in the Next 3 Years
Japan
LOE Scenario in Japanese Pharma Industry 2014–2015
Japanese Generics Market in 2014
Key Focus of Japanese Pharma Industry—“Quality”
The Philippines
Indonesia
Taiwan and Malaysia
Rest of Asia
India, Indonesia, Vietnam, and China to lead APAC
Strategies
First-mover Advantage: Case Study—Cymbalta
The Last Word
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Author | Siddharth Dutta |
| WIP Number | P860-01-00-00-00 |
| Is Prebook | No |
Patent Cliff and the Future of Generics in Asia
$2,450.00
Special Price $1,837.50 save 25 %